These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 28275218)
1. Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy. Cucchiara V; Yang JC; Mirone V; Gao AC; Rosenfeld MG; Evans CP Cancers (Basel); 2017 Jan; 9(1):. PubMed ID: 28275218 [TBL] [Abstract][Full Text] [Related]
2. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer. Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197 [TBL] [Abstract][Full Text] [Related]
3. Androgen Receptor-Related Non-coding RNAs in Prostate Cancer. Yang Y; Liu KY; Liu Q; Cao Q Front Cell Dev Biol; 2021; 9():660853. PubMed ID: 33869227 [TBL] [Abstract][Full Text] [Related]
4. Androgen receptors in hormone-dependent and castration-resistant prostate cancer. Shafi AA; Yen AE; Weigel NL Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952 [TBL] [Abstract][Full Text] [Related]
5. Fararjeh AS; Liu YN Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181727 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between epigenetics and tumor promoting androgen signaling in prostate cancer. Singh VK; Kainat KM; Sharma PK Vitam Horm; 2023; 122():253-282. PubMed ID: 36863797 [TBL] [Abstract][Full Text] [Related]
7. Role of the Androgen-Androgen Receptor Axis in the Treatment Resistance of Advanced Prostate Cancer: From Androgen-Dependent to Castration Resistant and Further. Fujimoto N J UOEH; 2016 Jun; 38(2):129-38. PubMed ID: 27302726 [TBL] [Abstract][Full Text] [Related]
8. Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer. Wen S; Niu Y; Huang H Asian J Urol; 2020 Jul; 7(3):203-218. PubMed ID: 33024699 [TBL] [Abstract][Full Text] [Related]
9. Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription. Jia L; Wu D; Wang Y; You W; Wang Z; Xiao L; Cai G; Xu Z; Zou C; Wang F; Teoh JY; Ng CF; Yu S; Chan FL Oncogene; 2018 Jun; 37(25):3340-3355. PubMed ID: 29555975 [TBL] [Abstract][Full Text] [Related]
10. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer. Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of resistance in castration-resistant prostate cancer (CRPC). Chandrasekar T; Yang JC; Gao AC; Evans CP Transl Androl Urol; 2015 Jun; 4(3):365-80. PubMed ID: 26814148 [TBL] [Abstract][Full Text] [Related]
12. Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells. Izumi K; Mizokami A J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30871130 [TBL] [Abstract][Full Text] [Related]
13. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells. Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225 [TBL] [Abstract][Full Text] [Related]
14. Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism. Shih JW; Wang LY; Hung CL; Kung HJ; Hsieh CL Int J Mol Sci; 2015 Dec; 16(12):28943-78. PubMed ID: 26690121 [TBL] [Abstract][Full Text] [Related]
17. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression. Komura K; Jeong SH; Hinohara K; Qu F; Wang X; Hiraki M; Azuma H; Lee GS; Kantoff PW; Sweeney CJ Proc Natl Acad Sci U S A; 2016 May; 113(22):6259-64. PubMed ID: 27185910 [TBL] [Abstract][Full Text] [Related]
18. The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program. Parolia A; Venalainen E; Xue H; Mather R; Lin D; Wu R; Pucci P; Rogalski J; Evans JR; Feng F; Collins CC; Wang Y; Crea F Mol Oncol; 2019 May; 13(5):1121-1136. PubMed ID: 30776192 [TBL] [Abstract][Full Text] [Related]